Skip to main content
OpenTrials
Completed

NCT Number: NCT03156608

Novii External Fetal Monitoring Device

This study will be conducted on women in labor. Fetal heart rate monitoring will be conducting using the Novii Fetal ECG/EMG system and comparing it to current standard of care external fetal heart rate and tocometry. These approaches will be compared with the respect to need for additional monitoring, amount of nursing intervention, cost and satisfaction of patients and healthcare providers.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Intermountain Medical Center, Murray, Utah, United States

Loading trial locations.

About this study

Interpretation of fetal heart rate monitoring during labor is one of the most common procedures performed in the practice of obstetrics. Continuous monitoring of the fetal heart rate is used to identify infants at risk for hypoxic ischemic encephalopathy and allow for intervention to prevent this terrible complication. The quality of the fetal heart rate signal is critical for appropriate interpretation of the characteristics that identify risk.

This is a prospective, randomized pragmatic trial comparing the Novii Fetal ECG/EMG system to external fetal heart rate and tocometry (standard of care) for the amount of time of interpretable fetal heart rate during labor. Randomization will occur in blocks based on BMI to control for the potential effect of BMI.

Fetal heart rate tracings from both groups of women will be reviewed in a blinded fashion by experienced Maternal Fetal Medicine (MFM) physicians who will assess the tracing for quality and interpretability. In addition, both approaches will be compared with respect to the need for additional monitoring modalities, amount of nursing intervention, cost and satisfaction of the patients and healthcare providers.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant women ≥ 18 years of age; gestational age ≥ 37 weeks
  • Singleton pregnancy.
  • These women will be those presenting to Labor and Delivery for one of the following:
  • Rule out labor
  • Spontaneous labor
  • Induction of labor

Exclusion criteria

  • Age < 18 years old; multiple gestation pregnancy; gestational age < 37 weeks
  • Fetal distress or vaginal bleeding prior to monitor placement
  • Previous cesarean section
  • Planned cesarean delivery.
  • Women who are enrolled in the study but have less than 1 hour of fetal heart rate monitoring after randomization will be excluded from analysis.

Treatment and study plan

Novii ECG/EKG System

Device

External fetal heart rate monitoring

External fetal heart rate monitoring

Device

External fetal heart rate monitoring

Primary outcomes

  1. Amount of time in minutes with the interpretable fetal heart rate tracing during the course of labor.

    Time frame: Time of randomization until time of delivery (up to 48 hours)

    Quality of the fetal heart rate for each minute of tracing will be assessed visually by 2 or more blinded reviewers. For the purpose of this study, uninterpretable fetal heart rate will be defined as continuous fetal heart rate data with one or more of the following:

    • Data is missing for more than 75% of the minute of tracing
    • Artifact is present for more than 25% of the minute of tracing
    • Missing data or artifact prevents determination of baseline rate
    • > 15 seconds of continuous missing tracing
    • Missing data is not continuous but is sufficiently frequent that the one minute segment of tracing could not be used to determine baseline rate

    The total number of interpretable minutes of fetal heart tracing and the percentage of time with interpretable fetal heart tracing over the course of labor (Number of minutes with interpretable FHR/Total number of minutes in labor) will be calculated for each patient.

Secondary outcomes

  1. Quality and interpretability of the FHT in ten minute segments

    Time frame: Time of randomization until time of delivery (up to 48 hours)

    a. Each 10 minute segment will be deemed to be interpretable if it meets all of the following criteria: i. Sufficient data are available to determine a baseline ii. Sufficient data are available to determine the variability of the tracing iii. Sufficient data are available to identify periodic changes in the tracing (e.g. accelerations, decelerations, etc) b. For each 10 minute segment that is called Uninterpretable, the reviewer will indicate the reason for this designation by selecting one of the following options: i. Poor signal quality due to missing data ii. Poor signal quality due to artifact iii. Adequate signal quality but intrinsic fetal heart rate makes interpretation impossible (e.g. marked variability, etc.)

  2. Number and quality of uterine contractions in each 10 minute segment:

    Time frame: Time of randomization until time of delivery (up to 48 hours)

    The number of uterine contractions per segment will be recorded b. Signal quality (amount of missing data or artifact) will be recorded

  3. Number and quality of uterine contractions in each 10 minute segment:

    Time frame: Time of randomization until time of delivery (up to 48 hours)

    Signal quality (amount of missing data or artifact) will be recorded

  4. Number of times fetal heart rate monitor requires adjusting:

    Time frame: Time of randomization until time of delivery (up to 48 hours)

    Measured by recording the number of times the nurse must adjust the monitoring system to obtain interpretable tracing

  5. Number of times fetal heart rate monitor requires adjusting:

    Time frame: Time of randomization until time of delivery (up to 48 hours)

    Number of times that hand holding of the monitor is required

  6. Need for additional monitoring devices such as change from Novii to standard monitoring devices or the use of intrauterine pressure catheter or fetal scalp electrode:

    Time frame: Time of randomization until time of delivery (up to 48 hours)

    Need for additional monitoring devices will be determined by the clinical care team including attending physician and/or nurses based on clinical judgment

  7. Need for additional monitoring devices such as change from Novii to standard monitoring devices or the use of intrauterine pressure catheter or fetal scalp electrode will be recorded by clinical care team:

    Time frame: Time of randomization until time of delivery (up to 48 hours)

    Reason 1: Poor signal quality - missing data Reason 2: Poor signal - artifact Reason 3: Need additional information (e.g. intrauterine pressure, etc.) Reason 4: Patient preference Reason 5: Provider preference

  8. Need for additional monitoring devices such as change from Novii to standard monitoring devices or the use of intrauterine pressure catheter or fetal scalp electrode will be recorded by clinical care team:

    Time frame: Time of randomization until time of delivery (up to 48 hours)

    Reason 2: Poor signal - artifact Reason 3: Need additional information (e.g. intrauterine pressure, etc.) Reason 4: Patient preference Reason 5: Provider preference

  9. Need for additional monitoring devices such as change from Novii to standard monitoring devices or the use of intrauterine pressure catheter or fetal scalp electrode will be recorded by clinical care team:

    Time frame: Time of randomization until time of delivery (up to 48 hours)

    Reason 3: Need additional information (e.g. intrauterine pressure, etc.) Reason 4: Patient preference Reason 5: Provider preference

  10. Need for additional monitoring devices such as change from Novii to standard monitoring devices or the use of intrauterine pressure catheter or fetal scalp electrode will be recorded by clinical care team:

    Time frame: Time of randomization until time of delivery (up to 48 hours)

    Reason 4: Patient preference Reason 5: Provider preference

  11. Need for additional monitoring devices such as change from Novii to standard monitoring devices or the use of intrauterine pressure catheter or fetal scalp electrode will be recorded by clinical care team:

    Time frame: Time of randomization until time of delivery (up to 48 hours)

    Reason 5: Provider preference

  12. Nursing time required for care:

    Time frame: Time of randomization until time of delivery (up to 48 hours)

    We will record the amount of time that the nurses spend at the bedside to adjust the monitor b. Nurses will record the time and reasons that they enter the room

  13. Nursing time required for care:

    Time frame: Time of randomization until time of delivery (up to 48 hours)

    Nurses will record the time and reasons that they enter the room

  14. Overall cost of care:

    Time frame: Hospitalization for labor, delivery, and recovery - 2-4 days

    Total charge for care from admission to Labor and Delivery to transfer to postpartum care will be recorded for all patients

  15. Overall cost of care:

    Time frame: Hospitalization for labor, delivery, and recovery - 2-4 days

    Delivery type and indication

  16. Maternal outcomes - Length of labor

    Time frame: Hospitalization for labor, delivery, and recovery - 2-4 days

    Length of labor recorded

  17. Maternal outcomes - Delivery type

    Time frame: Hospitalization for labor, delivery, and recovery - 2-4 days

    Type of delivery recorded (e.g., vaginal, cesarean section, etc.)

  18. Maternal outcomes - Indication for forceps/vacuum extraction or cesarean section, if performed

    Time frame: Hospitalization for labor, delivery, and recovery - 2-4 days

    Clinical indication for forceps/vacuum extraction or cesarean section delivery

  19. Maternal outcomes - Estimated blood loss

    Time frame: Hospitalization for labor, delivery, and recovery - 2-4 days

    Amount of blood loss (cc) recorded

  20. Maternal outcomes - Presence and severity of perineal lacerations

    Time frame: Hospitalization for labor, delivery, and recovery - 2-4 days

    Lacerations and degree of laceration recorded

  21. Maternal outcomes - Intra-amniotic infection (clinical chorioamnionitis or triple I)

    Time frame: Hospitalization for labor, delivery, and recovery - 2-4 days

    Infections documented

  22. Maternal outcomes - Presence of clinical endometritis

    Time frame: Hospitalization for labor, delivery, and recovery - 2-4 days

    Endometritis diagnosis recorded

  23. Neonatal outcomes - APGAR Scores

    Time frame: Hospitalization after delivery - 2-4 days

    APGAR scores recorded at 1 minute, 5 minutes, and 10 minutes

  24. Neonatal outcomes - Need for ICU Admission

    Time frame: Hospitalization after delivery - 2-4 days

    Recorded NICU admission

  25. Neonatal outcomes - Birthweight

    Time frame: Hospitalization after delivery - 2-4 days

    Infant birthweight (grams)

  26. Neonatal outcomes - Neonatal Sex

    Time frame: Hospitalization after delivery - 2-4 days

    Neonatal sex recorded

  27. Patient and provider satisfaction - Patient Survey

    Time frame: Up to 7 days after delivery

    Satisfaction survey completed by patient after delivery of infant

  28. Patient and provider satisfaction - Nurse Survey

    Time frame: Up to 7 days after delivery

    Satisfaction survey completed by nurse attending labor/delivery after delivery of infant

  29. Patient and provider satisfaction - Attending Physician/Midwife Survey

    Time frame: Up to 7 days after delivery

    Satisfaction survey completed by physician/midwife attending labor/delivery after delivery of infant

Sponsors and collaborators

Lead sponsor

Intermountain Health Care, Inc.

Other

Collaborators

  • GE Healthcare

Registry information

Official study title

Evaluation of the Novii External Fetal Monitoring Device: A Prospective, Randomized Comparison

Acronym: Novii

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
May 17, 2017
Registry last updated
Nov 1, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.